Who is sponsoring NCT03102892?

NCT03102892 is sponsored by University of Sao Paulo.

What drugs are being tested in NCT03102892?

Interventions in NCT03102892: Scaling root planing, Antimicrobial photodynamic therapy.

What condition does NCT03102892 study?

NCT03102892 studies Diabetes Mellitus, Type 1, Periodontal Diseases, Periodontal Pocket.

Is NCT03102892 still recruiting?

NCT03102892 is currently terminated. Last updated 8 March 2023.

Last reviewed 2023-03-08 · How we verify

NCT03102892

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Antimicrobial Photodynamic Therapy on Periodontal Treatment and Salivary Status of Type 1 Diabetes Mellitus Patients

Terminated NA Last updated 8 March 2023

What this trial tests

NA trial testing Scaling root planing in Diabetes Mellitus, Type 1 in 60 participants. Terminated before completion.

Timeline

24 April 2017

Primary endpoint
13 March 2020

13 March 2020

Quick facts

Lead sponsor	University of Sao Paulo
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	24 April 2017
Primary completion	13 March 2020
Estimated completion	13 March 2020
Sites	1 location across Brazil

Drugs / interventions tested

Scaling root planing
Antimicrobial photodynamic therapy

Conditions studied

Diabetes Mellitus, Type 1 — all drugs for Diabetes Mellitus, Type 1 →
Periodontal Diseases — all drugs for Periodontal Diseases →
Periodontal Pocket — all drugs for Periodontal Pocket →

Sponsor

University of Sao Paulo

Who can join

Adults 18 to 65, any sex, with Diabetes Mellitus, Type 1 or Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate adjuvant effect of antimicrobial photodynamic therapy in periodontal treatment and salivary status of type 1 diabetes patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Adjuvant antimicrobial photodynamic therapy improves periodontal health and reduces inflammatory cytokines in patients with type 1 diabetes mellitus.
Cunha PO, Gonsales IR, Greghi SLA, Sant'ana ACP, et al · · 2024 · cited 6× · PMID 39383343 · DOI 10.1590/1678-7757-2024-0258

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 1

Currently open trials in the same condition.

NCT07325461 — Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes · NA · recruiting
NCT07305805 — A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes · Phase 1 · recruiting
NCT06282055 — Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes · recruiting
NCT06325202 — Closed Loop and Education for Hypoglycemia Awareness Restoration · NA · recruiting
NCT07160816 — A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar · recruiting

Other University of Sao Paulo trials

Trials by the same sponsor.

NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07522554 — Lavender and Lemongrass Aromatherapy for Pain and Anxiety in Labor: A Randomized Trial · NA · active not recruiting
NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
NCT07445178 — Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopi · completed
NCT07170007 — Physiotherapeutic Protocol Compared to Usual Care in the Treatment of Primiparas After Perineal Trauma · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03102892 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo
Last refreshed: 8 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03102892.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing